During liver insufficiency, besides portasystemic shunting, high arterial glutamine concentrations could enhance intestinal glutamine consumption and ammonia generation, thereby aggravating hyperammonaemia. To investigate this hypothesis, portal drained viscera (intestines) fluxes and jejunal tissue concentrations of ammonia and glutamine were measured in portacaval shunted rats with a ligated bile duct, portacaval shunted, and sham operated rats, seven and 14 days after surgery, and in normal unoperated controls. Effects of differences in food intake were minimised by pair feeding portacaval shunted and sham operated with portacaval shunted rats with biliary obstruction. At both time points, arterial ammonia was increased in the groups with liver insufficiency. Also, arterial glutamine concentration was raised in ali operated groups compared with normal unoperated controls. At both time points, ammonia production by portal drained viscera was reduced in portacaval shunted rats with biliary obstruction, portacaval shunted, and sham operated rats compared with normal unoperated controls, and no major differences were found between these operated groups. At day 7 in ali operated groups glutamine uptake by portal drained viscera was lower than in normal unoperated controls, but no major differences were found at day 14. These experiments show that ammonia generation by portal drained viscera remains unchanged in rats with chronic liver insufficiency despite alterations in arterial glutamine concentrations and intestinal glutamine uptake. The hyperammonaemia seems to be mainly determined by the portasystemic shunting. (Gut 1993; 34: 
Ammonia is still considered to be of crucial importance in the pathogenesis of hepatic encephalopathy.' The gut and kidney are generally considered to be the most important sites of ammonia production.2'-In the gut, the main sources of ammonia production are the bacterial breakdown of urea2 367 and the mucosal utilisation of glutamine as an energy substrate.2 37I In the physiological situation virtually all ammonia generated in the gut is immediately cleared by hepatic urea synthesis, and thus hepatic venous ammonia concentrations are lower than arterial concentrations. Therefore, in healthy subjects, systemic ammonia concentrations are probably mainly set by the interaction between renal ammonia production and ammonia consumption by other organs. During liver cirrhosis induced by chronic liver disease this situation changes drastically, because ammonia generated in the intestines bypasses hepatic clearance by intra or extrahepatic portasystemic shunts.910 Also, the diminished urea synthesis and glutamine synthetase capacity9' may reduce ammonia detoxification in the liver. These combined factors probably cause the systemic hyperammonaemia found during liver insufficiency.
It has been suggested that systemic hyperammonaemia during chronic liver failure leads to enhanced ammonia detoxification via alternative pathways.'2 It is generally believed that the energy dependent synthesis of glutamine from equimolar amounts of glutamate and ammonia is the most important of these pathways. ' 3 This glutamine synthesis in organs containing glutamine synthetase, mainly skeletal muscle and brain,'4 probably contributes to the raised arterial glutamine concentrations during hyperammonaemia induced by liver insufficiency. '2 Because intestinal glutamine uptake is concentration dependent,7 these increased arterial glutamine concentrations in turn could increase intestinal glutamine utilisation and subsequent liberation of ammonia.
A considerable amount of research has been performed concerning several aspects of ammonia and glutamine metabolism during acute and chronic liver insufficiency (see for example,4612 I 15-18 and also our laboratory '9 20) . Despite the well known effects of food intake on nitrogen metabolism in general and more specifically on glutamine and ammonia metabolism,2' few studies have been performed under conditions of controlled food intake during hyperammonaemia induced by liver insufficiency.
The hypothesis underlying the present study was that during chronic liver insufficiency, besides portasystemic shunting, high arterial glutamine concentrations could aggravate hyperammonaemia by enhanced (6) 59 (12) 199 (19) h 1% (20) 68 (7) 181 (26) (7) 79 (14) 55 (5) ' 61 (7) 66 (7) 40(4) b"kP Glutamine 554 (12) 592 (20) 644 (23) 713 (40) 604 (24) 609 (17) 599 (27) (Table II) were increased in PCS-PF compared with PF rats, as noted previously,27 and in PCSBDL rats compared with PCS-PF rats. In both hyperammonaemic groups, arterial glucose concentrations were decreased and lactate concentrations were raised in comparison with PF rats (Table II) . Portal drained viscera plasma flow (Table III) was decreased in the PF group at day 7 when compared with normal unoperated control rats, but no further differences in portal plasma flow were found between the PCSBDL, PCS-PF, and PF groups.
AMMONIA
Arterial ammonia concentrations were raised equally in PCSBDL and PCS-PF rats on both day 7 and day 14 . No major differences in ammonia production by portal drained viscera were found between PCSBDL, PCS-PF, and PF rats, and ammonia production by portal drained viscera in the hyperammonaemic groups never exceeded that in normal control rats. In fact, it was lower in all operated groups at day 7 compared with normal unoperated controls. Although no major changes occurred in ammonia release by portal drained viscera ammonia concentrations in jejunal tissue were raised in both hyperammonaemic groups (Fig 2; Tables II-IV) .
GLUTAMINE
Arterial glutamine concentrations were always higher in PCSBDL, PCS-PF, and PF than in normal rats. Also, at day 7 arterial glutamine concentrations were raised in PCSBDL compared with PF rats, but no differences were found at day 14 portal drained viscera was enhanced in both hyperammonaemic groups compared with sham operated animals, mainly caused by a reduced portal vein plasma flow in the PF group. No major differences were found at day 14. Although arterial glutamine concentrations were always higher in the hyperammonaemic groups, glutamine uptake by portal drained viscera never exceeded that in normal controls. Simultaneously, jejunal glutamine concentrations were raised in PCSBDL compared with PF rats at both time points. The changes in glutamine and ammonia handling make it of special interest to look at some key metabolites intimately related to the intestinal breakdown of glutamine -namely, alanine, glutamate, and citrulline (Fig  3; Tables II-IV) .
ALANINE
Arterial alanine concentrations were raised in both chronic liver insufficiency groups at both times. Alanine efflux from portal drained viscera was decreased overall in the PCSBDL group compared with both PF and PCS-PF rats (ANOVA days 7 to 14). Also, at day 14 alanine release was lower in the PCS-PF group compared with PF rats. Despite these changes, no major differences in tissue alanine were found (Fig 4; Tables II-IV 
Discussion
The present experiments were designed to study intestinal ammonia and amino acid metabolism during hyperammonaemia induced by chronic liver insufficiency. Specifically, we were interested in whether raised arterial glutamine concentrations during chronic liver insufficiency would lead to enhanced intestinal glutamine uptake and subsequent ammonia release, thereby aggravating the already existing portasystemic shunting induced hyperammonaemia. To minimise the influence of differences in nutritional state, rats were studied under conditions of well controlled food intake. Studies were performed one and two weeks after surgery, as we have previously shown that button portacaval shunted rats recover from several of the metabolic disturbances ofportacaval shunting after three to four weeks, probably due to the development of hepatopetal shunts.23
In the current experiments, the similar food intake and body weight in PCSBDL, PCS-PF, and PF rats suggests that differences between PCS-PF and PF rats are due to portacaval shunting. Similarly, differences between PCSBDL and PCS-PF rats are related to the aggravated hepatic parenchymal injury and cholestatic jaundice, induced by prolonged biliary obstruction.2 2 Arterial ammonia concentrations were raised equally in PCS-PF and PCSBDL rats, compared with both PF and normal control rats. This was found at day 14, when intestinal ammonia production was similar in normal, PF, PCS-PF, and PCSBDL rats, as well as at day 7 when ammonia liberation was decreased in all operated groups compared with normal rats. The intestinal ammonia release in normal unoperated control rats was in close aggreement with data previously reported by our group.'9 From these data it seems that the (degree of) hyperammonaemia in both chronic liver insufficiency groups is mainly caused by the existence of a portasystemic shunt and not by enhanced intestinal ammonia production. Although the PCSBDL group undoubtedly has more severe parenchymal damage than the PCS-PF group, arterial ammonia concentrations were similar. This could easily by interpreted as evidence that the residual liver function is still able to detoxify total Although arterial glutamine concentrations were always higher in the PF, PCS-PF, and PCSBDL groups than in normal control rats, glutamine uptake by portal drained viscera in the PF, PCS-PF, and PCSBDL groups never exceeded that in normal control rats. The glutamine uptake in portal drained viscera in normal controls was similar to data recently reported by our group.'9 Also, although the raised arterial glutamine concentrations at day 7 in PCSBDL rats compared with PF rats resulted in increased glutamine uptake by portal drained viscera, this was not accompanied by a significantly increased intestinal release of ammonia. Finally, the fractional glutamine extraction of about 30% in normal controls, closely resembling that reported by Windmueller and Spaeth,78 decreased in the hyperammonaemic groups. The hypothesis underlying this study was that hyperglutaminaemia during chronic liver insufficiency would enhance intestinal glutamine consumption and subsequent ammonia release, thus aggravating the already existing portasystemic shunting induced hyperammonaemia. From the present data we conclude that this hypothesis does not apply to these hyperammonaemia models in the rat.
There were several other interesting findings. The changes in jejunal tissue concentrations are difficult to interpret. The increased tissue glutamine concentrations in both hyperammonaemic groups suggest that glutamine breakdown in the glutaminase reaction is diminished, which seems supported by the decreased glutamine uptake and fractional glutamine extraction. This does not seem compatible with the simultaneously raised concentrations ofglutamate and ammonia, the products of the glutaminase reaction. Because intestinal glutamine synthetase activity is low,'428 probably the only plausible alternative explanation for increased jejunal glutamine concentrations is enhanced intestinal breakdown of protein. This should lead to enhanced intestinal release of essential amino acids, however, which was not found either. Thus presumably the changes reflect the end result of a new equilibrium, in which raised intestinal ammonia concentrations'3 partially inhibit mucosal glutaminase activity. The glutaminase reaction, yielding energy for the gut,28 can then only be driven at the expense of raised tissue glutamine concentrations, provided by uptake of blood derived glutamine. Also in the light of this, the decreased tissue BCAA concentrations in the PCSBDL group could be due to enhanced BCAA transamination, providing glutamate and a ketoglutarate for energy. Firm conclusions are, however, not justified based on the present data.
In the present experiments, portacaval anastomosis combined with common bile duct ligation was introduced as a model to study nitrogen metabolism during chronic liver insufficiency. Construction of a portacaval anastomosis alone induces, besides portasystemic shunting of gut derived blood, a relative and absolute reduction of liver mass. 15-17 37 Urea synthesis capacity is limited in portacaval shunted rats, probably related to the reduced liver mass.'5"6 To these effects of portacaval anastomosis alone, the effects of chronic bile duct ligation were added. Prolonged common bile duct ligation induces periportal fibrosis, portal hypertension, and portasystemic shunting293' as well as metabolic dysfunction of the liver.303' Although the resulting jaundice is of a different aetiology from that commonly encountered in cirrhotic patients, it is also cholestatic and therefore introduces impaired cell mediated immunity and Kupffer cell dysfunction3131 in the model of portacaval shunting with biliary obstruction. Because portacaval shunted rats with biliary obstruction showed subtle signs pointing to more pronounced hepatic encephalopathy, we think that the portacaval shunt and biliary obstruction model could be useful in future studies on the pathophysiology of chronic liver insufficiency and the related hepatic encephalopathy.
In conclusion, these experiments show that under conditions of standardised food intake, ammonia generation by portal drained viscera remained unchanged in rats with chronic liver insufficiency despite alterations in arterial glutamine and intestinal glutamine uptake. This suggests that arterial ammonia concentrations in these rats are mainly determined by the existence of portasystemic shunting and not by arterial glutamine concentrations, intestinal glutamine uptake, or ammonia liberation. Finally, portacaval shunting combined with common bile duct ligation seems to be a useful model to study nitrogen metabolism during mild hyperammonaemia induced by chronic liver insufficiency in rats.
